Press Releases

All News
By Year:
2019
2018
2017
2016
2015
2014
2013

08/15/16

Arch Therapeutics Reports AC5 Topical Hemostatic Device Meets Primary and Secondary Endpoints in First Clinical Study

06/6/16

Arch Therapeutics Completes Patient Enrollment in Clinical Study of AC5

05/27/16

Arch Therapeutics Announces May 26, 2016 $3.4 Million Private Placement

05/16/16

Arch Therapeutics Announces Issuance of Composition of Matter Patent Covering Self-Assembling Peptidomimetics

05/10/16

Arch Therapeutics Receives Notice of Allowance for Composition of Matter and Method of Use Patent Covering Solid Forms of Self-Assembling Peptides

04/26/16

Arch Therapeutics to Present at PIONEERS 2016 by Joseph Gunnar & Co. Thursday, May 5, 2016

04/25/16

Arch Therapeutics Receives Notice of Allowance for Patent Covering Systemic Applications for Self-Assembling Peptides

04/11/16

Arch Therapeutics Announces Notice of Allowance for Method of Use Patent Covering Uses of Self-Assembling Peptides

04/5/16

Arch Therapeutics Announces Notice of Allowance for Composition-of-Matter Patent Covering Self-Assembling Peptides

03/22/16

Arch Therapeutics Obtains Favorable Safety Data for AC5 Surgical Hemostatic Device(TM) in Skin Irritation Testing in Humans

<< Previous
1
2
3
4
5
6
7
Next >>

Show All